We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Diagnosis Errors Can Harm Patients

By HospiMedica staff writers
Posted on 13 Oct 2005
A new study reveals that procedures used to obtain and examine tissue for cancer diagnosis are prone to error that often results in harm to patients. More...
The findings are reported in the November 15, 2005, issue of Cancer.

A government-mandated error-detection method that involves the review of patient specimens, when patients have two or more specimens from the same body site, found that up to 12% of reviewed specimen pairs had an erroneous diagnosis. Pathologists failed to agree on the cause of most of these errors. Before this, the cause of errors in cancer diagnosis has not been well studied, due in part to the lack of national standards to detect errors.

Researchers at the University of Pittsburgh School of Medicine (PA, USA) reviewed tissue specimens, pathologists' findings, and medical records from four institutions that diagnose precancerous and cancerous lesions. They also reviewed patient material when the diagnoses differed on multiple tests from the same patient. They found that errors were relatively frequent and institution-dependent. Up to 9% of gynecologic specimen pairs (Pap test and cervical biopsy) contained an error and up to 12% of other specimen pairs contained an error. Institutional differences in error rates are probably related to bias in error reporting.

The majority of errors were a result of suboptimal specimen collection, while the proportion of errors caused by pathologist misinterpretation ranged from 5-50%. When pathologists reviewed specimens from other institutions, they frequently disagreed with the assignment of error cause. A review of medical records showed that gynecologic errors resulted in harm in 45% of cases, while other errors resulted in harm in 39% of cases. Pathologists also disagreed on the severity of harm caused by an error in cancer diagnosis.

According to the researchers, variability in practice impairs the ability to understand error cause. "The standardization and uniform reporting of errors in cancer diagnosis is the first step in improving safety,” concluded the authors.




Related Links:
U. of Pittsburgh

Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Temperature Monitor
ThermoScan Temperature Monitoring Unit
Digital X-Ray Detector Panel
Acuity G4
Infant Resuscitator
Easypuff
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.